Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CHIPMOS TECHNOLOGIES INC Board/Management Information 2019

Apr 25, 2019

32558_ffr_2019-04-25_395daf45-cca5-40e9-a238-3cefadb006da.zip

Board/Management Information

Open in viewer

Opens in your device viewer

6-K 1 d728803d6k.htm FORM 6-K Form 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April, 2019

Commission File Number 001-37928

ChipMOS TECHNOLOGIES INC.

(Translation of Registrant’s Name Into English)

No. 1, R&D Rd. 1, Hsinchu Science Park

Hsinchu, Taiwan

Republic of China

(Address of Principal Executive Offices)

(Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.)

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: April 25, 2019
(Registrant)
By: /S/ S. J. Cheng
Name: S. J. Cheng
Title: Chairman & President

2

Hsinchu, Taiwan, April 25, 2019 — On April 25, 2019, ChipMOS TECHNOLOGIES INC. (the “Company”) (Taiwan Stock Exchange: 8150 and NASDAQ: IMOS) held the 26 th meeting of its 8 th Board of Directors (the “Board”), at which the following matters were resolved and public announcements were made in Taiwan regarding such resolutions:

(1) The Company’s 2018 Annual Report Form 20-F (including the English 2018 consolidated financial statements prepared by the Company in accordance with the International Financial Reporting Standards); and

(2) The appointment of Mr. JB Chyi, a senior director of the Company, to replace Mr. Jesse Huang as the Company’s Research and Development officer with the effective date of April 25, 2019.

Mr. Jesse Huang remains the Company’s Spokesperson and Vice President of Strategy and Investor Relations.